Benzydamine hydrochloride

ApprovedSmall molecule

SSeoul National University Hospital

Benzydamine hydrochloride is one of 35 small molecule programs targeting Oral Mucositis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Oral MucositisActive, not recruiting

Oral MucositisApproved

Active, not recruiting

Competition

Competitive Landscape

132 competitors in Oral Mucositis

#DrugCompanyPhaseTrials

Afinitor

Novartis

Phase 3

1 2

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

3 3

Cytoxan

BBaxter Healthcare Corporation

Phase 3

2 4

Duragesic

CCephalon

Phase 3

2 5

Bactroban

PPadagis LLC

Phase 3

1 6

Neurontin

VViatris Specialty LLC

Phase 3

1 7

Benadryl

PParkedale

Phase 3

1 8

Curcumin

Merck & Co.

Phase 3

2 9

N-Acetyl Cyteien

SStanford University

Phase 3

2 10

Zinc Acetate

NNobelpharma

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1Not yet recruiting

Sore Throat

NCT06676748

Clinical

Trials by Indication[1]

Oral Mucositis2 trials

Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy

Completed·TTishreen University·Phase 4·NCT07467759·35 enrolled

The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy

Unknown status·—·Phase 2·NCT05323058·42 enrolled

Preoperative1 trial

Preoperative Aspirin and Benzydamine Hydrochloride Gargles on Severity and Duration of Post-Operative Sore Throat

Unknown status·RRehman Medical Institute - RMI·Phase 4·NCT05343429·60 enrolled

Sore Throat1 trial

Benzydamine Hydrochloride and Post-operative Sore Throat

Not yet recruiting·KKK Women's and Children's Hospital·Phase 1·NCT06676748·106 enrolled

Post Operative Sore Throat1 trial

Effect of Benzydamine Hydrochloride to Postoperative Sore Throat in Pediatric Patients

Completed·SSeoul National University Hospital·Phase 4·NCT03074968·142 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Benzydamine hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Benzydamine hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Benzydamine hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SSeoul National University Hospital

Benzydamine hydrochloride

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Oral Mucositis2 trials

Preoperative1 trial

Sore Throat1 trial

Post Operative Sore Throat1 trial

References

Drug Info

Quick Facts

Related News